1Rozemuller E H,Kropveld A,Kreyveld E, et al. Sensitive detection of p53 mutation: analysis by direct sequencing and nmhisequence analysis[J]. Cancer Detect,2001,25(2) : 109-116.
2Somasundaram K. Tumor suppressor p53.regulation and function [J].Front Biosci ,2000 , 5 : 13424-437.
4Vogelstein B, Fearon E R, Hamilton S R, et al. Genetic alterations during colorectal-tumor development [J 1. N Engl J Med, 1988,319(9) : 525-532.
5Bell S M, Scott N, Crcxss D, et al. Prognostic value of p53 over- expression and c-ki-ras gene mutation in colorectal cancer []]. Gastroenterelogy, 1993,104 ( 1 ) : 57-64.
6Smith D R, Ji C Y, Goh H S. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas[J].Br J Cancer,1996,74(2) :216-223.
7Hoffman W H, Biade S, Zilfou J T, et al. Transcriptional represion of the anti-apoptotic survivin gene by wild type P53 [J] .J Biol Chem,2002,277(5):3247-3257.
8Mirza A, McGuirk M, Hockenberry T N, et al. Human survivin is negatively regulated by wild-type P53 and participates in p53-dependent apoptotic pathway [J]. Oncogene, 2002, 21 (17) :2 613-2622.
10Bahnasy A A, Zekri A R, EI-Housini S, et al. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients [ J ]. BMC Gastroenterol, 2004,4 (22) : 221-222.
二级参考文献17
1[1]Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell,1990;61:759～67
2[2]Carethers JM. The cellular and molecular pathogenesis of colo-rectal cancer. Gastroenterology, 1996;25: 737～54
3[3]Mosmann TR,Cherwinski H,Bond MW et al. Two types of murine helper T cell clone. J Immunol,1986;136:2348～57
4[4]Huang M,Wang J, Lee P et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res, 1995;55:3847～53
5[5]Ainsworth PJ, Rodenhiser DI. A non radioactive method for the detection of single-strand conformational polymorphisms (SSCP). Meth Mol Biol, 1994;31:205～11
6[6]Crabtree JE,shallcross TM,Heatley RV et al. Mucosal tumour necrosis factor γ and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut,1991;32:1473～7
7[7]Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature,1991;351:453～6
8[8]Yamaguchi A,Kurosaka Y,Fushida S et al. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer,1992;70:2778～82
9[9]Hall PA, Meek DP, Lane DP. p53-integrating the complexity.J Pathol,1996;180:1～5
10[10]Maggi E,Biswas P,Del Prete GF et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjun-ctivitis. J Immunol,1991;146:1169～74
8Prives C,,Hall PA.The p53pathway. Journal of Paleopathology . 1999
9Crighton D,Wilkinson S,O′Prey J,et al.DRAM,a p53-induced modulator of autophagy,is critical for apoptosis. Cell . 2006
10Petitjean A,Mathe E,Kato S,et al.Impact of mutant p53functional properties on TP53mutation patterns and tumor phenotype:lessons from recent developments in the IARC TP53database. Human Mutation . 2007
